Ficoll-Paque™ PREMIUM products are a range of sterile, ready to use density gradient media for the preparation of mononuclear cells.

Ficoll-Paque® reagents are designed to prepare human mononuclear cells from peripheral blood, bone marrow, and umbilical cord blood via density gradient centrifugation. These sterile density media have established a proven record of isolating high yields of mononuclear cells. Both Ficoll-Paque® PLUS and PREMIUM media exhibit consistently low endotoxin levels (\<0.12 EU/mL).

• Manufactured according to GMP and ISO 13485:2003 standards and the recommendations of the United States Pharmacopeia
• Sterile and ready to use
• Low levels of endotoxin (<0,12 EU/ml) secured and tested
• Non cytotoxic

Ficoll-Paque™ PREMIUM products are a range of sterile, ready to use density gradient media for the preparation of mononuclear cells.

Sterile, ready to use reagents used to prepare mononuclear cell preparations from peripheral blood, bone marrow, and umbilical cord blood by density gradient centrifugation. Liquid physical state. Colorless to slightly yellow. Manufactured under a Quality Management System certified to ISO 13485:2003. Ficoll-Paque® reagents are designed to prepare human mononuclear cells from peripheral blood, bone marrow, and umbilical cord blood via density gradient centrifugation. These sterile density media have established a proven record of isolating high yields of mononuclear cells. Both Ficoll-Paque® PLUS and PREMIUM media exhibit consistently low endotoxin levels (<0.12 EU/ml). A Regulatory Support File (RSF) is available for Ficoll-Paque PREMIUM products.

Sterile, ready to use reagents used to prepare mononuclear cell preparations from peripheral blood, bone marrow, and umbilical cord blood by density gradient centrifugation. Liquid physical state. Colorless to slightly yellow. Manufactured under a Quality Management System certified to ISO 13485:2003. Ficoll-Paque® reagents are designed to prepare human mononuclear cells from peripheral blood, bone marrow, and umbilical cord blood via density gradient centrifugation. These sterile density media have established a proven record of isolating high yields of mononuclear cells. Both Ficoll-Paque® PLUS and PREMIUM media exhibit consistently low endotoxin levels (<0.12 EU/ml). A Regulatory Support File (RSF) is available for Ficoll-Paque PREMIUM products.

Ficoll-Paque PLUS is a sterile, ready-to-use density media containing Ficoll PM400, sodium diatrizoate and disodium calcium EDTA. The density has been optimized for the isolation of human lymphocytes from peripheral blood. For research use only.

Ficoll-Paque PREMIUM products are based on Ficoll-Paque PLUS (see Ficoll-Paque PLUS) which has been used for more than 30 years as a sterile density medium for the isolation of high yields of mononuclear cells from bone marrow, peripheral blood, and cord blood. All Ficoll-Paque PREMIUM products differ from Ficoll-Paque PLUS in that they are manufactured under a Quality Management System certified to ISO 13485:2003. They constitute a range of sterile, ready-to-use density media containing Ficoll PM400, sodium diatrizoate and disodium calcium EDTA in water for injection (WFI). The densities and osmolalities of the different products have been optimized for the isolation of mononuclear cells from human peripheal blood, bone marrow, and umbilical cord blood.

Ficoll-Paque PREMIUM 1.084 can be used for isolating a broad range of human mononuclear cells including those of a higher density and for separating blood cells from mice or rats.

Ficoll-Paque PREMIUM 1.073 can be used when isolating lower-density human mononuclear cells (e.g., mesenchymal stromal cells or monocytes).